Guiyang Xintian Pharmaceutical (002873.SZ) controlling shareholder New Sky Intelligent Medicine plans to reduce holdings by no more than 7.05 million shares.

Guiyang Xintian Pharmaceutical (002873.SZ) announcement, the company's controlling shareholder Shanghai Xintian Intelligent Pharmaceutical Biotechnology Co., Ltd. (referred to as "Xintian Intelligent Pharmaceutical") plans to reduce its holding of the company's shares through block trades and centralized bidding transactions from November 11, 2025 to February 10, 2026, totaling no more than 7.05 million shares, accounting for 2.9962% of the total share capital after deducting the shares in the company's repurchase special account.